A randomized, double-blind, multicenter study to evaluate the tolerability and effectiveness of etoricoxib 90 mg q.d. vs diclofenac sodium 75 mg b.i.d in patients with rheumatoid arthritis.

Trial Profile

A randomized, double-blind, multicenter study to evaluate the tolerability and effectiveness of etoricoxib 90 mg q.d. vs diclofenac sodium 75 mg b.i.d in patients with rheumatoid arthritis.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Sep 2014

At a glance

  • Drugs Diclofenac; Etoricoxib
  • Indications Arthritis; Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
  • Focus Adverse reactions; Registrational
  • Acronyms EDGE II
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 01 Mar 2008 Gastrointestinal tolerability results published in the Annals of the Rheumatic Diseases 67: 315-322, No. 3, Mar 2008.
    • 14 Nov 2006 Status change
    • 27 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top